What authority did the Dietary Supplement and Nonprescription Drug Consumer Protection Act of 2006 give to the FDA?

The Dietary Supplement and Nonprescription Drug Consumer Protection Act of 2006 enhances the authority of the FDA by allowing it to remove unsafe dietary supplements and over-the-counter (OTC) products from the market. This legislation was established to improve the safety monitoring of dietary supplements and to ensure that any product that poses a significant risk to consumers can be swiftly addressed.

Before this act, the FDA had a more limited ability to respond to adverse events related to dietary supplements. The law requires manufacturers to notify the FDA if they have information that a dietary supplement or OTC product has caused a serious adverse event, thereby equipping the FDA with the necessary tools to take action against dangerous products. This focus on consumer safety directly aligns with the intent of the act and reinforces the FDA's role in protecting public health.

The other choices either suggest authorities that the FDA does not possess, such as regulating prices or conducting clinical trials, or imply an overreach of authority that is not covered under this act. For instance, while the FDA oversees clinical trials, it does not have specific mandates related to dietary supplements under the scope of this act.